Respiratory Diagnostics Market Projected to Reach $9.02 Billion by 2030

Posted on
by

Respiratory Diagnostics Market Projected to Reach $9.02 Billion by 2030
Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) – Global Forecast to 2030.

According to MarketsandMarkets™, The report ” Respiratory Diagnostics Market by Product & Services (Instrument & Devices), Test type (Mechanical, OSA, Imaging, Molecular Test), Disease (Tuberculosis, COPD, Lung Cancer ) and Diagnosis Type (Syndromic, Aetiological, Prognosis) – Global Forecast to 2030″, is expected to reach USD 9.02 billion by 2030 from USD 6.17 billion in 2024, at a CAGR of 6.5%, during the forecast period.

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=163390459

 

Browse

  • 489 Market Data Tables
  • 71 Figures
  • 403 Pages and in-depth TOC on “Respiratory Diagnostics Market – Global Forecast to 2030”.

 

Some of the prominent key players are:

  • Koninklijke Philips N.V. (Netherlands),
  • Becton, Dickinson and Company (US),
  • Abbott Laboratories (US),
  • Thermo Fisher Scientific Inc. (US),
  • GE Healthcare Technologies Inc. (US),
  • Bio-Rad Laboratories, Inc. (US),
  • Blomerieux (France),
  • Revvity, Inc. (US), and many more……

 

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Respiratory Diagnostics Market.

 

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=163390459

  • These point-of-care tests are taking health care into a number of different places which is expanding the markets for instruments and devices. Portable diagnostic devices, including hand-held spirometers, peak flow meters, and mobile imaging devices, can allow for immediate evaluation of lung function and conditions.
  • The molecular diagnostic segment of tests is expected to register the highest growth rate during the forecast period in the respiratory diagnostic market. This trend is attributed to the growing demand for accurate and rapid diagnostics, particularly in the detection of respiratory infections such as COVID-19 and influenza as well as other viral diseases.
  • Personalized asthma management increasingly relies on complex and advanced tools of diagnosis, with regard to the individually focused patients. Such advanced diagnostics for asthma like molecular testing and biomarker analyses help providers to explore the various genetics and molecular bases behind a patient’s asthma.
  • Among the various type of diagnosis syndromic is expected to grow at a very fast rate in the global respiratory diagnostics market, as it is capable of rapidly identifying a broad range of organisms with a single diagnostic test. It allows the clinician to institute the most appropriate management in the least possible time, especially in an urgent care setting.
  • With the increasing trend, hospitals and clinics are accepting respiratory diagnostics as a complete part of the routine care model. Seamless inclusion of respiratory diagnostics in hospitals and clinics affords convenience for patients to access diagnostic services, whether they come from seeking primary care or specialized services for a problem.
  • North America accounted for the largest share in the respiratory diagnostics market in 2023. Awareness about timely diagnosis and proper management of diseases concerning the respiratory tract is one of the main factors driving the use of respiratory diagnostics products and services in North America.

 

Government efforts towards prevention and management of respiratory diseases, along with enabling healthcare policies, higher funding, and support, will further facilitate the adoption of advanced diagnostic technology. Technological advancements in diagnostic methods, including imaging techniques, molecular diagnostics, and rapid methods, improve respiratory diagnosis accuracy and efficiency. Technological improvement always drives market growth through the provision of better diagnostic tools. More peculiar input in healthcare necessitates the recognition of both professionals and the general population on the importance of early detection and diagnosis of respiratory diseases. High costs incurred in most advanced imaging and molecular diagnostic respiratory tests have become barriers to accessibility and adoption thereby limiting market growth in resource-constrained regions.

 

Related Reports:

Infectious Disease Diagnostics Market – Global Forecast to 2030

Respiratory Care Devices Market – Global Forecast to 2030

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com